Galmed Pharmaceuticals Ltd. (GLMD) Jumped On Phase 2 Study Results

Galmed Pharmaceuticals Ltd. (GLMD) reported results from its Phase 2 study of Aramchol 600mg Tuesday morning. The study demonstrated a statistically significant reduction in liver fat.

from RTT - Before the Bell https://ift.tt/2HKkWoN
via IFTTT